Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Cid

Showing results (181-190 of 288) with videos related to

Pageof 29
Sort By:
Journal of Veterinary Internal Medicine|March 12, 2025
Iatrogenic Primary Hypothyroidism Associated With Sulfamethoxazole-Trimethoprim Treatment of Nocardiosis in a CatDeborah Alexander, Gustavo C Cobucci, Cassia C da Motta, et al.
Frontiers in Endocrinology|July 28, 2025
Risk factors for glucocorticoid induced osteoporosis in young adultsHelena Florez, Josep Lluis Carrasco, Martina Barberá, et al.
Seminars in Arthritis and Rheumatism|December 10, 2013
Treatment with angiotensin II receptor blockers is associated with prolonged relapse-free survival, lower relapse rate, and corticosteroid-sparing effect in patients with giant cell arteritisMarco A Alba, Ana García-Martínez, Sergio Prieto-González, et al.
Rheumatology (Oxford, England)|August 30, 2011
Tissue and serum markers of inflammation during the follow-up of patients with giant-cell arteritis--a prospective longitudinal studySudha Visvanathan, Mahboob U Rahman, Gary S Hoffman, et al.
Circulation Research|June 13, 2020
B55α/PP2A Limits Endothelial Cell Apoptosis During Vascular Remodeling: A Complementary Approach To Disrupt Pathological Vessels?Manuel Ehling, Ward Celus, Rosa Martín-Pérez, et al.
The Lancet. Rheumatology|January 27, 2024
Long-term effect of tocilizumab in patients with giant cell arteritis: open-label extension phase of the Giant Cell Arteritis Actemra (GiACTA) trialJohn H Stone, Jian Han, Martin Aringer, et al.
Arthritis and Rheumatism|May 14, 1999
Interferon-alpha may exacerbate cryoblobulinemia-related ischemic manifestations: an adverse effect potentially related to its anti-angiogenic activityM C Cid, J Hernández-Rodríguez, J Robert, et al.
Arthritis and Rheumatism|March 4, 2008
Development of aortic aneurysm/dilatation during the followup of patients with giant cell arteritis: a cross-sectional screening of fifty-four prospectively followed patientsAna García-Martínez, José Hernández-Rodríguez, Pedro Arguis, et al.
Annals of the Rheumatic Diseases|January 24, 2012
Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiographySergio Prieto-González, Pedro Arguis, Ana García-Martínez, et al.
Blood|August 6, 2014
SOX11 promotes tumor angiogenesis through transcriptional regulation of PDGFA in mantle cell lymphomaJara Palomero, Maria Carmela Vegliante, Marta Leonor Rodríguez, et al.
Pageof 29

Showing results (181-190 of 288) with videos related to

Sort By:
Pageof 29
Journal of Veterinary Internal Medicine|March 12, 2025
Iatrogenic Primary Hypothyroidism Associated With Sulfamethoxazole-Trimethoprim Treatment of Nocardiosis in a CatDeborah Alexander, Gustavo C Cobucci, Cassia C da Motta, et al.
Frontiers in Endocrinology|July 28, 2025
Risk factors for glucocorticoid induced osteoporosis in young adultsHelena Florez, Josep Lluis Carrasco, Martina Barberá, et al.
Seminars in Arthritis and Rheumatism|December 10, 2013
Treatment with angiotensin II receptor blockers is associated with prolonged relapse-free survival, lower relapse rate, and corticosteroid-sparing effect in patients with giant cell arteritisMarco A Alba, Ana García-Martínez, Sergio Prieto-González, et al.
Rheumatology (Oxford, England)|August 30, 2011
Tissue and serum markers of inflammation during the follow-up of patients with giant-cell arteritis--a prospective longitudinal studySudha Visvanathan, Mahboob U Rahman, Gary S Hoffman, et al.
Circulation Research|June 13, 2020
B55α/PP2A Limits Endothelial Cell Apoptosis During Vascular Remodeling: A Complementary Approach To Disrupt Pathological Vessels?Manuel Ehling, Ward Celus, Rosa Martín-Pérez, et al.
The Lancet. Rheumatology|January 27, 2024
Long-term effect of tocilizumab in patients with giant cell arteritis: open-label extension phase of the Giant Cell Arteritis Actemra (GiACTA) trialJohn H Stone, Jian Han, Martin Aringer, et al.
Arthritis and Rheumatism|May 14, 1999
Interferon-alpha may exacerbate cryoblobulinemia-related ischemic manifestations: an adverse effect potentially related to its anti-angiogenic activityM C Cid, J Hernández-Rodríguez, J Robert, et al.
Arthritis and Rheumatism|March 4, 2008
Development of aortic aneurysm/dilatation during the followup of patients with giant cell arteritis: a cross-sectional screening of fifty-four prospectively followed patientsAna García-Martínez, José Hernández-Rodríguez, Pedro Arguis, et al.
Annals of the Rheumatic Diseases|January 24, 2012
Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiographySergio Prieto-González, Pedro Arguis, Ana García-Martínez, et al.
Blood|August 6, 2014
SOX11 promotes tumor angiogenesis through transcriptional regulation of PDGFA in mantle cell lymphomaJara Palomero, Maria Carmela Vegliante, Marta Leonor Rodríguez, et al.
Pageof 29